BPTH
Income statement / Annual
Last year (2024), Bio-Path Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Bio-Path Holdings, Inc.'s net income was -$9.89 M.
See Bio-Path Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$37.00 K |
$13.00 K |
$0.00 |
| Cost of Revenue |
$0.00
|
$178.00 K
|
$178.00 K
|
$161.00 K
|
$151.00 K
|
$230.00 K
|
$426.00 K
|
$0.00
|
$0.00
|
$201.76 K
|
| Gross Profit |
$0.00
|
-$178.00 K
|
-$178.00 K
|
-$161.00 K
|
-$151.00 K
|
-$230.00 K
|
-$426.00 K
|
$37.00 K
|
$13.00 K
|
-$201.76 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
| Research and Development Expenses |
$7.30 M
|
$11.61 M
|
$9.17 M
|
$5.91 M
|
$6.58 M
|
$4.59 M
|
$4.60 M
|
$5.48 M
|
$5.47 M
|
$3.02 M
|
| General & Administrative Expenses |
$4.70 M
|
$4.11 M
|
$4.74 M
|
$4.53 M
|
$4.33 M
|
$4.11 M
|
$3.38 M
|
$3.52 M
|
$3.01 M
|
$2.46 M
|
| Selling & Marketing Expenses |
$0.00
|
$123.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.70 M
|
$4.24 M
|
$4.74 M
|
$4.53 M
|
$4.33 M
|
$4.11 M
|
$3.38 M
|
$3.52 M
|
$3.01 M
|
$2.46 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$608.00 K
|
$0.00
|
$0.00
|
$196.66 K
|
| Operating Expenses |
$11.99 M
|
$15.84 M
|
$13.90 M
|
$10.44 M
|
$10.91 M
|
$8.69 M
|
$7.98 M
|
$9.00 M
|
$8.49 M
|
$5.48 M
|
| Cost And Expenses |
$0.00
|
$15.84 M
|
$13.90 M
|
$10.44 M
|
$10.91 M
|
$8.69 M
|
$7.98 M
|
$9.00 M
|
$8.49 M
|
$5.48 M
|
| Interest Income |
$14.00 K
|
$36.00 K
|
$33.00 K
|
$3.00 K
|
$26.00 K
|
$94.00 K
|
$7.00 K
|
$9.00 K
|
$12.00 K
|
$17.67 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$82.00 K
|
$178.00 K
|
$161.00 K
|
$151.00 K
|
$230.00 K
|
$426.00 K
|
$411.00 K
|
$204.00 K
|
$201.76 K
|
| EBITDA |
$0.00 |
-$15.76 M |
-$13.69 M |
-$10.28 M |
-$10.73 M |
-$8.37 M |
-$8.16 M |
-$8.56 M |
-$8.27 M |
-$5.27 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-231.22
|
-636.23
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-242.32
|
-651.92
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
-$235.00 K
|
$33.00 K
|
$3.00 K
|
$26.00 K
|
$94.00 K
|
$7.00 K
|
$1.94 M
|
$1.73 M
|
$18.21 K
|
| Income Before Tax |
-$9.89 M
|
-$16.08 M
|
-$13.87 M
|
-$10.44 M
|
-$10.88 M
|
-$8.60 M
|
-$8.58 M
|
-$7.02 M
|
-$6.75 M
|
-$5.47 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-189.81
|
-519.23
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$33.00 K
|
-$3.00 K
|
-$26.00 K
|
-$94.00 K
|
-$608.00 K
|
-$1.94 M
|
-$1.73 M
|
$0.00
|
| Net Income |
-$9.89 M
|
-$16.08 M
|
-$13.84 M
|
-$10.44 M
|
-$10.86 M
|
-$8.51 M
|
-$8.58 M
|
-$7.02 M
|
-$6.75 M
|
-$5.47 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-189.81
|
-519.23
|
0
|
| EPS |
-4.12 |
-33.64 |
-38.03 |
-31.04 |
-56.44 |
-64.02 |
-287.54 |
-278.69 |
-291.26 |
-243.61 |
| EPS Diluted |
-4.12 |
-33.64 |
-38.03 |
-31.04 |
-56.44 |
-64.02 |
-287.54 |
-278.69 |
-291.26 |
-243.61 |
| Weighted Average Shares Out |
$2.40 M
|
$478.00 K
|
$363.80 K
|
$336.25 K
|
$192.35 K
|
$132.85 K
|
$29.85 K
|
$25.20 K
|
$23.18 K
|
$22.44 K
|
| Weighted Average Shares Out Diluted |
$2.40 M
|
$478.00 K
|
$363.80 K
|
$336.25 K
|
$192.35 K
|
$132.85 K
|
$29.85 K
|
$25.20 K
|
$23.18 K
|
$22.44 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
